3rd Annual Anti-Fibrotic Drug Development (AFDD) Summit

3rd Annual Anti-Fibrotic Drug Development (AFDD) Summit is organized by Hanson Wade and will be held from Nov 18 - 20, 2019 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America.

Description:
With 3 days of in-depth cutting-edge case studies and the highest calibre of industry and academic discussions, 3rd Anti-fibrotic Drug Development Summit (AFDD) will provide the roadmap to anti-fibrotic drug development success.

Hear from pharma and biotech companies of all sizes, as well as clinicians and leading academics for a complete picture of the current challenges and opportunities. Find commonalities across disease areas that can be applied back at the lab with presentations from specialists across all fibrotic conditions including NASH, IPF, CKD, cardiovascular, gastro-intestinal, Scleroderma, rare disease and ocular fibrosis.

This year’s AFDD Summit will help you to:
• Gain insights into the latest novel molecules and pathways to identify the best fibrotic mechanism to target
• Explore opportunities for combination therapies in fibrosis and oncology
• Ensure successful translation from in vivo and in vitro models to clinical trial through the consistent application of biomarkers and clinical endpoints

Time: 8:30 am - 4:30 pm

 Additional details will be posted as soon as information available.